Sara Nik

Stock Analyst at HC Wainwright & Co.

(2.38)

# 2,103

Out of 5,050 analysts

6

Total ratings

50%

Success rate

14.71%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CDTX Cidara Therapeutics	Reiterates: Buy	$150	$104.39	+43.69%	4	Oct 21, 2025
	MBRX Moleculin Biotech	Reiterates: Buy	$4	$0.49	+718.00%	2	Sep 10, 2025

Cidara Therapeutics

Oct 21, 2025

Reiterates: Buy

Price Target: $150

Current: $104.39

Upside: +43.69%

Moleculin Biotech

Sep 10, 2025

Reiterates: Buy

Price Target: $4

Current: $0.49

Upside: +718.00%